Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
(Carbidopa + levodopa) by Contera Pharma for Parkinson's Disease: Likelihood of Approval
(Carbidopa + levodopa) is under clinical development by Contera Pharma and currently in Phase I for Parkinson's Disease. According to...
Data Insights
(Carbidopa + levodopa) by Amneal Pharmaceuticals for Parkinson's Disease: Likelihood of Approval
(Carbidopa + levodopa) is under clinical development by Amneal Pharmaceuticals and currently in Pre-Registration for Parkinson's Disease. According to GlobalData,...